Skip to main content
Premium Trial:

Request an Annual Quote

Diamir Publishes Data on microRNA Biomarkers of Mild Cognitive Impairment

Premium

Privately held molecular diagnostics company Diamir announced this week the publication of data by company researchers showing that two families of miRNAs can be used to detect mild cognitive impairment, a condition associated with the early stage of neurodegenerative disorders such as Alzheimer's disease.

According to the data, which appeared in Aging, members of the miR-132 and miR-134 families were detected in plasma and used to identify patients with mild cognitive impairment with an overall accuracy of 96 percent and 87 percent, respectively.

"We will focus on conducting larger studies and developing a test with the goal of making it available to the scientific and medical community as quickly as possible," Diamir CEO Kira Sheinerman said in a statement.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.